Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueInventory Average

RedHill Biopharma (RDHL) Operating Margin (2016 - 2023)

Historic Operating Margin for RedHill Biopharma (RDHL) over the last 12 years, with Q2 2023 value amounting to 2992.87%.

  • RedHill Biopharma's Operating Margin rose 29429500.0% to 2992.87% in Q2 2023 from the same period last year, while for Jun 2023 it was 122.98%, marking a year-over-year increase of 79700.0%. This contributed to the annual value of 181.69% for FY2024, which is 3751300.0% down from last year.
  • As of Q2 2023, RedHill Biopharma's Operating Margin stood at 2992.87%, which was up 29429500.0% from 808.0% recorded in Q1 2023.
  • RedHill Biopharma's 5-year Operating Margin high stood at 2992.87% for Q2 2023, and its period low was 808.0% during Q1 2023.
  • In the last 5 years, RedHill Biopharma's Operating Margin had a median value of 90.03% in 2020 and averaged 336.14%.
  • As far as peak fluctuations go, RedHill Biopharma's Operating Margin tumbled by -15231400bps in 2021, and later soared by 29429500bps in 2023.
  • RedHill Biopharma's Operating Margin (Quarter) stood at 739.87% in 2019, then tumbled by -88bps to 91.83% in 2020, then crashed by -798bps to 641.43% in 2021, then rose by 8bps to 591.81% in 2022, then skyrocketed by 606bps to 2992.87% in 2023.
  • Its Operating Margin was 2992.87% in Q2 2023, compared to 808.0% in Q1 2023 and 591.81% in Q4 2022.